Literature DB >> 21358686

The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study.

R E Protheroe1, K E Kirkland, R M Pearce, K Kaminaris, A Bloor, M N Potter, S Nagra, M H Gilleece, I G McQuaker, G Jackson, G Cook, D I Marks.   

Abstract

The clinical course of 2009 H1N1 influenza in Allo-SCT patients is unknown. Data were collected in the UK from October 2009 to April 2010 on laboratory-confirmed cases of H1N1 influenza in Allo-SCT recipients. H1N1 infection was diagnosed in 60 patients, median age 42 years, at a median of 10 months post-SCT. Twenty-one patients (35%) developed pneumonia and nine (15%) required admission to intensive care units. Actuarial mortality was 7% at 28 days and 19% 4 months post-diagnosis of 2009 H1N1 influenza. Increasing age and pre-existing lung disease were risk factors for pneumonia (P=0.006 and 0.037, respectively); older age was a risk factor for death (P=0.012). Morbidity and mortality from 2009 H1N1 influenza in SCT patients exceeds that of immunocompetent patients, but parallels that in other critically ill hospitalised cohorts; the elderly and those with chronic pulmonary disease are at greatest risk.

Entities:  

Mesh:

Year:  2011        PMID: 21358686     DOI: 10.1038/bmt.2011.12

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

Review 1.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

Review 2.  Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Authors:  Christian Renaud; Angela P Campbell
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

Review 3.  Vaccination of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.

Authors:  Mini Kamboj; Monika K Shah
Journal:  Infect Dis Clin North Am       Date:  2019-06       Impact factor: 5.982

Review 4.  Influenza prevention and treatment in transplant recipients and immunocompromised hosts.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

5.  Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index.

Authors:  Joumana Kmeid; Jakapat Vanichanan; Dimpy P Shah; Firas El Chaer; Jacques Azzi; Ella J Ariza-Heredia; Chitra Hosing; Victor Mulanovich; Roy F Chemaly
Journal:  Biol Blood Marrow Transplant       Date:  2015-11-27       Impact factor: 5.742

6.  Lung irradiation increases mortality after influenza A virus challenge occurring late after exposure.

Authors:  Casey M Manning; Carl J Johnston; Christina K Reed; B Paige Lawrence; Jacqueline P Williams; Jacob N Finkelstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-27       Impact factor: 7.038

7.  Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study.

Authors:  Maria Cecilia Dignani; Patricia Costantini; Claudia Salgueira; Rosana Jordán; Graciela Guerrini; Alejandra Valledor; Fabián Herrera; Andrea Nenna; Claudia Mora; Inés Roccia-Rossi; Daniel Stecher; Edith Carbone; Ana Laborde; Ernesto Efron; Javier Altclas; Aníbal Calmaggi; José Cozzi
Journal:  F1000Res       Date:  2014-09-12

Review 8.  Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.

Authors:  Aeron C Hurt; David S Hui; Alan Hay; Frederick G Hayden
Journal:  Influenza Other Respir Viruses       Date:  2014-11-15       Impact factor: 4.380

Review 9.  Viral Respiratory Tract Infections in Allogeneic Hematopoietic Stem Cell Transplantation Recipients in the Era of Molecular Testing.

Authors:  Starling A Sim; Vivian K Y Leung; David Ritchie; Monica A Slavin; Sheena G Sullivan; Benjamin W Teh
Journal:  Biol Blood Marrow Transplant       Date:  2018-03-09       Impact factor: 5.742

Review 10.  Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients.

Authors:  Cécile Pochon; Sebastian Voigt
Journal:  Front Microbiol       Date:  2019-01-09       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.